Mizuho Securities analyst Ann Hynes reiterated a Buy rating on Tenet Healthcare (THC) yesterday and set a price target of $32. The company’s shares closed yesterday at $26.64.
According to TipRanks.com, Hynes is a 3-star analyst with an average return of 3.5% and a 53.5% success rate. Hynes covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Acadia Healthcare, and Cardinal Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $33.13 average price target, representing a 24.4% upside. In a report issued on November 6, Robert W. Baird also reiterated a Buy rating on the stock with a $35 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $39.74 and a one-year low of $12.45. Currently, Tenet Healthcare has an average volume of 1.35M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
